NM_001130004.2:c.515+193T>C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001130004.2(ACTN1):​c.515+193T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.6 in 152,060 control chromosomes in the GnomAD database, including 28,059 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.60 ( 28059 hom., cov: 32)

Consequence

ACTN1
NM_001130004.2 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0190

Publications

4 publications found
Variant links:
Genes affected
ACTN1 (HGNC:163): (actinin alpha 1) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a nonmuscle, cytoskeletal, alpha actinin isoform and maps to the same site as the structurally similar erythroid beta spectrin gene. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
ACTN1 Gene-Disease associations (from GenCC):
  • platelet-type bleeding disorder 15
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • autosomal dominant macrothrombocytopenia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 14-68909762-A-G is Benign according to our data. Variant chr14-68909762-A-G is described in ClinVar as Benign. ClinVar VariationId is 1294078.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001130004.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTN1
NM_001130004.2
MANE Select
c.515+193T>C
intron
N/ANP_001123476.1
ACTN1
NM_001424012.1
c.515+193T>C
intron
N/ANP_001410941.1
ACTN1
NM_001424013.1
c.641+193T>C
intron
N/ANP_001410942.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTN1
ENST00000394419.9
TSL:1 MANE Select
c.515+193T>C
intron
N/AENSP00000377941.4
ACTN1
ENST00000538545.6
TSL:1
c.515+193T>C
intron
N/AENSP00000439828.2
ACTN1
ENST00000193403.11
TSL:1
c.515+193T>C
intron
N/AENSP00000193403.6

Frequencies

GnomAD3 genomes
AF:
0.599
AC:
91088
AN:
151942
Hom.:
28024
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.678
Gnomad AMI
AF:
0.569
Gnomad AMR
AF:
0.554
Gnomad ASJ
AF:
0.533
Gnomad EAS
AF:
0.935
Gnomad SAS
AF:
0.794
Gnomad FIN
AF:
0.647
Gnomad MID
AF:
0.611
Gnomad NFE
AF:
0.520
Gnomad OTH
AF:
0.574
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.600
AC:
91178
AN:
152060
Hom.:
28059
Cov.:
32
AF XY:
0.612
AC XY:
45509
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.678
AC:
28126
AN:
41472
American (AMR)
AF:
0.554
AC:
8470
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.533
AC:
1847
AN:
3466
East Asian (EAS)
AF:
0.935
AC:
4822
AN:
5158
South Asian (SAS)
AF:
0.794
AC:
3832
AN:
4824
European-Finnish (FIN)
AF:
0.647
AC:
6850
AN:
10592
Middle Eastern (MID)
AF:
0.609
AC:
179
AN:
294
European-Non Finnish (NFE)
AF:
0.520
AC:
35312
AN:
67956
Other (OTH)
AF:
0.579
AC:
1222
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1851
3703
5554
7406
9257
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.523
Hom.:
38326
Bravo
AF:
0.588
Asia WGS
AF:
0.843
AC:
2927
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
4.3
DANN
Benign
0.29
PhyloP100
0.019
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs743127; hg19: chr14-69376479; API